Skip to content
Medical Health Aged Care

INTRODUCING OUR SAGE TELEHEALTH SERVICES

Cornerstone Health 2 mins read

In a commitment to making a difference to Australian healthcare, Cornerstone Health introduces its newest healthcare service – Our Sage telehealth services.

Over the last two years, telehealth has been used by many Australian families and is an accepted part of our healthcare system. Telehealth allows parents to stay at home and still get care for their children or themselves when they are unwell while also providing easier access to healthcare for people who are not able to easily attend a face to face consultation. Our Sage will provide access to telehealth services from 7am to 11pm (AET) Australia-wide, every day of the year.  

 

Cornerstone Health is uncompromising in putting patients at the heart of all they do. With this philosophy, Our Sage’s mission is to improve virtual patient care in Australia. The best form of general practice is face to face, however for when an in-person consult is not available, Our Sage is the next best alternative.

 

Our Sage will take the same patient-focused approach that Cornerstone Health’s network of medical centres, Our Medical, is known for, and bring this online. The network of Our Sage doctors are all registered, experienced GPs operating to RACGP standards and guidelines.

 

Today’s virtual care trend is being exploited by online pharmacies, to sell discretionary “healthcare“ products, focusing on issues such as hair loss and erectile disfunction. At Our Sage, our focus is squarely on healthcare provided by real General Practitioners to patients - when they cannot get access to a face to face consult with their usual general practitioner. Our Sage is a digital platform offering a range of primary healthcare services, quality care in accordance with RACGP standards and guidelines.

Cornerstone Health CEO and Founder, Henry Bateman

 

All Our Sage telehealth consultations are privately charged for Medicare and non-Medicare card holders. The standard fee is $45 for consults up to 15 minutes.

 

Along with access to General Practitioners via remote consultations, Our Sage telehealth consultations can also help patients with:

  • Online medical certificates
  • Online prescriptions
  • Online pathology or radiology requests and specialist referrals

 

Patients can join the queue for a telehealth consult via the Our Sage app or website. Further information can be found at oursage.com.au

More from this category

  • Medical Health Aged Care
  • 08/12/2025
  • 10:11
BeOne Medicines Ltd.

Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies

Novel BCL2 inhibitor sonrotoclax monotherapy demonstrates deep and durable clinical responses in R/R MCL and R/R CLL Sonrotoclax in combination with BRUKINSA demonstrated rapid…

  • Contains:
  • Medical Health Aged Care
  • 08/12/2025
  • 09:40
Miltenyi Biomedicine

Miltenyi Biomedicine presents primary analysis of the pivotal DALY 2-EU trial for second-line relapsed/refractory large B-cell lymphoma at the 67th American Society of Hematology (ASH) Annual Meeting

DALY 2-EU results show zamtocabtagene autoleucel (zamto-cel) demonstrated clinically meaningful superiority over chemoimmunotherapy in patients with relapsed/refractory large B-cell lymphoma (r/r LBCL)1Zamto-cel was well-tolerated in the majority of patients. DALY 2-EU included a high-risk study population, characterized by older age and clinically high-risk disease featuresA 12-day manufacturing time resulted in a vein-to-vein time of 14-16 days, reducing the likelihood for bridging therapy.BERGISCH GLADBACH, Germany, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Miltenyi Biomedicine today announced results from the pivotal DALY 2-EU trial evaluating the efficacy and safety of zamtocabtagene autoleucel (zamto-cel) compared with standard chemoimmunotherapy (R-GemOx or Pola-BR) in patients with…

  • Medical Health Aged Care, Seniors Interest
  • 08/12/2025
  • 08:56
Monash University

Men and women may need different medications to avoid broken bones

A new international study, published in Osteoporosis International and led by Monash’s Centre for Medicine Use and Safety (CMUS), investigated the risks of a…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.